Overview
- Hilo announced a $19 million Series B extension backed by the Dell Family Office and launched Hilo Core in the U.S. on Tuesday, July 21, 2026 to support its market expansion.
- Hilo Core is a three-part system that pairs a screenless wristband, a mobile app, and a wireless arm cuff to deliver about 30–35 blood pressure readings per day from the wrist.
- The system requires a four-day initial calibration with the supplied FDA-cleared arm cuff and then uses the wristband for frequent optical measurements with monthly cuff spot-checks to maintain accuracy.
- Hilo is selling the hardware for $89.99 with a mandatory $149.99 annual subscription and says the package is pre-approved for HSA/FSA eligibility.
- The company cites two decades of research, eight clinical studies and a 30,000-user real-world analysis showing larger blood-pressure drops among engaged users, and it enters a growing, competitive market that includes other cuffless startups and a projected device market expansion through 2033.